NEXSTAR PHARMACEUTICALS INC
424B3, 1999-04-06
PHARMACEUTICAL PREPARATIONS
Previous: LEUKOSITE INC, 8-K, 1999-04-06
Next: NATURAL MICROSYSTEMS CORP, DEF 14A, 1999-04-06



<PAGE>



                      SUPPLEMENT NO. 6 DATED APRIL 6, 1999
                       TO PROSPECTUS DATED OCTOBER 6, 1997
                                   RELATING TO
         $80,000,000 6 1/4% CONVERTIBLE SUBORDINATED DEBENTURES DUE 2004
                    INTEREST PAYABLE FEBRUARY 1 AND AUGUST 1
           AND SHARES OF COMMON STOCK ISSUABLE UPON CONVERSION THEREOF

     All capitalized terms used but not defined herein shall have the meanings
set forth in the Prospectus dated October 10, 1997, as previously supplemented
(the "Prospectus"), forming a part of the Registration Statement on Form S-3
(Registration No. 333-35827). Any cross references in this Supplement refer to
portions of the Prospectus.

     The purpose of this Supplement is to provide additional information
regarding the Selling Securityholders. In addition to the Selling
Securityholders named in the Prospectus, the following table sets forth the name
of each additional Selling Securityholder and relationship, if any, with the
Company and (i) the amount of Debentures owned by each additional Selling
Securityholder as of April 6, 1999 (subject to the qualification set forth
below), (ii) the maximum amount of Debentures which may be offered for the
account of such additional Selling Securityholder under the Prospectus, (iii)
the amount of Common Stock owned by each additional Selling Securityholder as of
April 6, 1999, and (iv) the maximum amount of Common Stock which may be offered
for the account of such Selling Securityholder under the Prospectus.

<TABLE>
<CAPTION>

                                                             Principal Amount    Shares of
                                         Principal Amount    of Debentures       Common Stock        Shares of
                                         of Debentures       Offered             Owned Prior to      Common Stock
Name of Selling Securityholder           Owned               Hereby              Offering (1)        Offered Hereby (2)
- ------------------------------           -----               ------              ------------        ------------------
<S>                                      <C>                 <C>                 <C>                 <C>
Q Investments, L.P.(3)...............     1,071,000           1,021,000              63,467              60,504
R 2 Investments, LDC (3).............     1,071,000           1,021,000              63,467              60,504
Forest Global  Convertible Fund
   Series A-5........................       940,000             940,000              55,704              55,704
Deephauen Market Neutral
   Trading Limited...................       550,000             550,000              32,593              32,593
Deephauen Market Neutral
   Trading LP........................       450,000             450,000              26,667              26,667
Forum Capital Markets LLC............        63,000              63,000               3,733               3,733
LLT Limited..........................        60,000              60,000               3,555               3,555
Total................................    $4,205,000          $4,105,000                 N/A             243,260
                                         ==========          ==========          ==========          ==========
- -----------------------
</TABLE>

(1)    Includes the shares of Common Stock into which the Debentures held by
       such Selling Securityholder are convertible at the initial conversion
       price. The conversion price and the number of shares of Common Stock
       issuable upon conversion of the Debentures are subject to adjustment
       under certain circumstances. See "Description of Debentures - Conversion
       Rights." Accordingly, the number of shares of Common Stock issuable upon
       conversion of the Debentures may increase or decrease from time to time.
       Fractional shares will not be issued upon conversion of the Debentures;
       rather, cash will be paid in lieu of fractional shares, if any.

(2)    Assumes conversion into Common Stock of the full amount of Debentures
       held by such Selling Securityholder at the initial conversion price. The
       conversion price and the number of shares of Common Stock issuable upon
       conversion of

<PAGE>


       the Debentures are subject to adjustment under certain circumstances.
       See "Description of Debentures Conversion Rights." Accordingly, the
       number of shares of Common Stock issuable upon conversion of the
       Debentures may increase or decrease from time to time. Fractional
       shares will not be issued upon conversion of the Debentures; rather,
       cash will be paid in lieu of fractional shares, if any.

(3)  Includes $50,000 aggregate principal amount of freely tradable Debentures.

     Because the Selling Securityholder may, pursuant to this Prospectus, offer
all or some portion of the Debentures and Common Stock it presently holds or,
with respect to Common Stock, has the right to acquire upon conversion of such
Debentures, no estimate can be given as to the amount of the Debentures and
Common Stock that will be held by the Selling Securityholder upon termination of
any such sales. In addition, the Selling Securityholder identified above may
have sold, transferred or otherwise disposed of all or a portion of its
Debentures and Common Stock since the date on which it provided the information
regarding its Debentures and Common Stock, in transactions exempt from the
registration requirements of the Securities Act of 1933. See "Plan of
Distribution."

     The Company may from time to time, in accordance with the Registration
Rights Agreement, include additional Selling Securityholders in future
supplements to the Prospectus.

     The Selling Securityholder listed above did not have any material
relationship with the Company other than as a result of ownership of the
Debentures, within the three-year period ending on the date of this Prospectus.




© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission